Among the cautious calls, analysts at Erste Group had downgraded the stock’s rating to a Hold from Buy on October 31. While the analysts acknowledged Netflix’s topline and earnings growth, they ...

Chris Raymond of Raymond James upgraded Monopar Therapeutics Inc. (MNPR) to an “Outperform” rating, marking a pivotal moment for the company and its investors. This upgrade reflects growing confidence ...

Fintel reports that on November 14, 2025, Raymond James downgraded their outlook for Monopar Therapeutics (NasdaqCM:MNPR) from Strong Buy to Outperform. Analyst Price Forecast Suggests 30.81% Upside ...

Nvidia shares have soared about 1,000% since the launch of ChatGPT in November 2022. This includes a year-to-date gain of ...

Raymond James recently welcomed financial advisors Hugo Porro and Manuel Porro to Raymond James & Associates (RJA) - the firm's employee advisor channel - according to Gregg Stupinski, South Atlantic ...

Cisco shares rose ahead of Q1 earnings as investors eye AI infrastructure demand to drive growth amid mixed Wall Street ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...

Raymond James reports 125 defense and government M&A deals in Q3 2025, a 30 percent rise, with major contracts and market ...

J.P. Morgan, Jefferies, Leerink Partners and Guggenheim Securities are acting as joint-book running managers for the Equity Offering. LifeSci Capital is acting as lead manager and Raymond James is ...

BP p.l.c. (NYSE:BP) is one of the best undervalued stocks to buy under $50. On November 4, Raymond James lifted the price ...

CoreWeave's third-quarter results also showed that the company has made progress on the path to profitability. It reported a net loss of $110 million, far below consensus estimates of a $245 million ...

J.P. Morgan, Jefferies, Leerink Partners and Guggenheim Securities are acting as joint-book running managers for the proposed Equity Offering. LifeSci Capital is acting as lead manager and Raymond ...